Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -9.42 Million USD | 58.81% |
| 2023 | -22.87 Million USD | -147.34% |
| 2022 | 48.3 Million USD | -20.65% |
| 2021 | 60.88 Million USD | 2.37% |
| 2020 | 59.47 Million USD | -1.16% |
| 2019 | 60.17 Million USD | -4.7% |
| 2018 | 63.14 Million USD | 44.19% |
| 2017 | 43.79 Million USD | 19.77% |
| 2016 | 36.56 Million USD | 9.06% |
| 2015 | 33.52 Million USD | 19.06% |
| 2014 | 28.15 Million USD | 3.56% |
| 2013 | 27.19 Million USD | 20.77% |
| 2012 | 22.51 Million USD | -1.43% |
| 2011 | 22.83 Million USD | 30.35% |
| 2010 | 17.52 Million USD | 26.29% |
| 2009 | 13.87 Million USD | 14.68% |
| 2008 | 12.09 Million USD | 32.58% |
| 2007 | 9.12 Million USD | 14.91% |
| 2006 | 7.94 Million USD | 34.23% |
| 2005 | 5.91 Million USD | 16.02% |
| 2004 | 5.09 Million USD | 6.52% |
| 2003 | 4.78 Million USD | 21.34% |
| 2002 | 3.94 Million USD | 24.45% |
| 2001 | 3.17 Million USD | 3.12% |
| 2000 | 3.07 Million USD | 33.65% |
| 1999 | 2.3 Million USD | 4.55% |
| 1998 | 2.2 Million USD | 22.22% |
| 1997 | 1.8 Million USD | 1000.0% |
| 1996 | -200 Thousand USD | -128.57% |
| 1995 | 700 Thousand USD | -22.22% |
| 1994 | 900 Thousand USD | 280.0% |
| 1993 | -500 Thousand USD | 37.5% |
| 1992 | -800 Thousand USD | 0.0% |
| 1991 | -800 Thousand USD | -300.0% |
| 1990 | -200 Thousand USD | 60.0% |
| 1989 | -500 Thousand USD | 54.55% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -2.02 Million USD | 42.01% |
| 2024 Q2 | -3.48 Million USD | -332.0% |
| 2024 Q4 | -5.41 Million USD | -167.8% |
| 2024 Q1 | 1.5 Million USD | -73.03% |
| 2024 FY | -9.42 Million USD | 58.81% |
| 2023 Q1 | 5.2 Million USD | -65.18% |
| 2023 Q2 | -41.84 Million USD | -903.24% |
| 2023 FY | -22.87 Million USD | -147.34% |
| 2023 Q3 | 8.19 Million USD | 119.57% |
| 2023 Q4 | 5.57 Million USD | -31.97% |
| 2022 Q3 | 5.44 Million USD | -49.73% |
| 2022 Q1 | 17.07 Million USD | 8.36% |
| 2022 Q4 | 14.95 Million USD | 174.83% |
| 2022 FY | 48.3 Million USD | -20.65% |
| 2022 Q2 | 10.82 Million USD | -36.59% |
| 2021 Q3 | 13.37 Million USD | -15.79% |
| 2021 FY | 60.88 Million USD | 2.37% |
| 2021 Q4 | 15.76 Million USD | 17.81% |
| 2021 Q2 | 15.88 Million USD | 0.16% |
| 2021 Q1 | 15.86 Million USD | -2.98% |
| 2020 Q4 | 16.34 Million USD | 33.99% |
| 2020 FY | 59.47 Million USD | -1.16% |
| 2020 Q1 | 14.65 Million USD | -7.35% |
| 2020 Q2 | 16.27 Million USD | 11.08% |
| 2020 Q3 | 12.2 Million USD | -25.04% |
| 2019 Q2 | 16.05 Million USD | 5.34% |
| 2019 Q1 | 15.23 Million USD | -13.15% |
| 2019 Q4 | 15.81 Million USD | 20.97% |
| 2019 Q3 | 13.07 Million USD | -18.55% |
| 2019 FY | 60.17 Million USD | -4.7% |
| 2018 Q1 | 11.91 Million USD | -4.49% |
| 2018 Q4 | 17.54 Million USD | 5.78% |
| 2018 Q3 | 16.58 Million USD | -3.01% |
| 2018 Q2 | 17.1 Million USD | 43.53% |
| 2018 FY | 63.14 Million USD | 44.19% |
| 2017 Q2 | 11.15 Million USD | 12.85% |
| 2017 FY | 43.79 Million USD | 19.77% |
| 2017 Q3 | 10.28 Million USD | -7.75% |
| 2017 Q4 | 12.47 Million USD | 21.26% |
| 2017 Q1 | 9.88 Million USD | 0.24% |
| 2016 FY | 36.56 Million USD | 9.06% |
| 2016 Q4 | 9.85 Million USD | 18.6% |
| 2016 Q1 | 9.32 Million USD | -0.65% |
| 2016 Q2 | 9.07 Million USD | -2.68% |
| 2016 Q3 | 8.31 Million USD | -8.4% |
| 2015 FY | 33.52 Million USD | 19.06% |
| 2015 Q4 | 9.38 Million USD | 25.89% |
| 2015 Q2 | 7.8 Million USD | -12.12% |
| 2015 Q3 | 7.45 Million USD | -4.51% |
| 2015 Q1 | 8.88 Million USD | 17.86% |
| 2014 Q3 | 6.57 Million USD | 5.93% |
| 2014 FY | 28.15 Million USD | 3.56% |
| 2014 Q1 | 7.83 Million USD | 11.48% |
| 2014 Q2 | 6.2 Million USD | -20.82% |
| 2014 Q4 | 7.53 Million USD | 14.63% |
| 2013 Q2 | 6.79 Million USD | 1.18% |
| 2013 Q4 | 7.03 Million USD | 5.71% |
| 2013 FY | 27.19 Million USD | 20.77% |
| 2013 Q1 | 6.71 Million USD | 11.38% |
| 2013 Q3 | 6.65 Million USD | -2.08% |
| 2012 Q2 | 5.23 Million USD | -12.77% |
| 2012 FY | 22.51 Million USD | -1.43% |
| 2012 Q4 | 6.02 Million USD | 14.95% |
| 2012 Q3 | 5.24 Million USD | 0.13% |
| 2012 Q1 | 6 Million USD | 0.72% |
| 2011 Q1 | 5.82 Million USD | 25.68% |
| 2011 Q2 | 6.11 Million USD | 4.91% |
| 2011 Q3 | 4.94 Million USD | -19.1% |
| 2011 Q4 | 5.96 Million USD | 20.59% |
| 2011 FY | 22.83 Million USD | 30.35% |
| 2010 Q4 | 4.63 Million USD | 19.4% |
| 2010 Q1 | 4.39 Million USD | 28.62% |
| 2010 Q2 | 4.61 Million USD | 4.89% |
| 2010 Q3 | 3.88 Million USD | -15.81% |
| 2010 FY | 17.52 Million USD | 26.29% |
| 2009 Q1 | 3.73 Million USD | 17.57% |
| 2009 FY | 13.87 Million USD | 14.68% |
| 2009 Q2 | 3.9 Million USD | 4.5% |
| 2009 Q3 | 2.82 Million USD | -27.63% |
| 2009 Q4 | 3.41 Million USD | 21.04% |
| 2008 Q3 | 2.65 Million USD | -18.32% |
| 2008 Q4 | 3.17 Million USD | 19.45% |
| 2008 FY | 12.09 Million USD | 32.58% |
| 2008 Q1 | 3.01 Million USD | 30.74% |
| 2008 Q2 | 3.25 Million USD | 8.07% |
| 2007 FY | 9.12 Million USD | 14.91% |
| 2007 Q4 | 2.3 Million USD | 15.73% |
| 2007 Q3 | 1.99 Million USD | -17.97% |
| 2007 Q2 | 2.42 Million USD | 0.83% |
| 2007 Q1 | 2.4 Million USD | 23.01% |
| 2006 Q1 | 2.14 Million USD | 48.1% |
| 2006 Q2 | 2.21 Million USD | 3.41% |
| 2006 Q3 | 1.63 Million USD | -26.25% |
| 2006 Q4 | 1.95 Million USD | 19.85% |
| 2006 FY | 7.94 Million USD | 34.23% |
| 2005 Q4 | 1.44 Million USD | 19.03% |
| 2005 Q3 | 1.21 Million USD | -27.39% |
| 2005 Q2 | 1.67 Million USD | 5.56% |
| 2005 Q1 | 1.58 Million USD | 47.9% |
| 2005 FY | 5.91 Million USD | 16.02% |
| 2004 Q1 | 1.3 Million USD | 1.64% |
| 2004 FY | 5.09 Million USD | 6.52% |
| 2004 Q4 | 1.07 Million USD | -9.47% |
| 2004 Q3 | 1.18 Million USD | -23.33% |
| 2004 Q2 | 1.54 Million USD | 18.51% |
| 2003 Q1 | 1.07 Million USD | -3.33% |
| 2003 Q2 | 1.4 Million USD | 30.33% |
| 2003 Q3 | 1.03 Million USD | -26.48% |
| 2003 Q4 | 1.28 Million USD | 24.37% |
| 2003 FY | 4.78 Million USD | 21.34% |
| 2002 Q1 | 862 Thousand USD | -6.71% |
| 2002 Q3 | 826 Thousand USD | -27.86% |
| 2002 Q4 | 1.11 Million USD | 34.62% |
| 2002 Q2 | 1.14 Million USD | 32.83% |
| 2002 FY | 3.94 Million USD | 24.45% |
| 2001 Q1 | 672 Thousand USD | -48.35% |
| 2001 Q2 | 860 Thousand USD | 27.98% |
| 2001 Q3 | 714 Thousand USD | -16.98% |
| 2001 Q4 | 924 Thousand USD | 29.41% |
| 2001 FY | 3.17 Million USD | 3.12% |
| 2000 Q1 | 800 Thousand USD | 300.0% |
| 2000 FY | 3.07 Million USD | 33.65% |
| 2000 Q4 | 1.3 Million USD | 107.5% |
| 2000 Q3 | 627 Thousand USD | 109.0% |
| 2000 Q2 | 300 Thousand USD | -62.5% |
| 1999 Q3 | 600 Thousand USD | -14.29% |
| 1999 FY | 2.3 Million USD | 4.55% |
| 1999 Q1 | 800 Thousand USD | 300.0% |
| 1999 Q2 | 700 Thousand USD | -12.5% |
| 1999 Q4 | 200 Thousand USD | -66.67% |
| 1998 Q3 | 700 Thousand USD | 0.0% |
| 1998 Q4 | 200 Thousand USD | -71.43% |
| 1998 FY | 2.2 Million USD | 22.22% |
| 1998 Q2 | 700 Thousand USD | 16.67% |
| 1998 Q1 | 600 Thousand USD | 20.0% |
| 1997 Q2 | 400 Thousand USD | 0.0% |
| 1997 FY | 1.8 Million USD | 1000.0% |
| 1997 Q4 | 500 Thousand USD | 0.0% |
| 1997 Q1 | 400 Thousand USD | 166.67% |
| 1997 Q3 | 500 Thousand USD | 25.0% |
| 1996 Q4 | -600 Thousand USD | -700.0% |
| 1996 FY | -200 Thousand USD | -128.57% |
| 1996 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q1 | 100 Thousand USD | -66.67% |
| 1995 Q1 | 200 Thousand USD | -33.33% |
| 1995 Q2 | 200 Thousand USD | 0.0% |
| 1995 Q3 | 100 Thousand USD | -50.0% |
| 1995 FY | 700 Thousand USD | -22.22% |
| 1995 Q4 | 300 Thousand USD | 200.0% |
| 1994 FY | 900 Thousand USD | 280.0% |
| 1994 Q2 | 300 Thousand USD | 200.0% |
| 1994 Q3 | 200 Thousand USD | -33.33% |
| 1994 Q4 | 300 Thousand USD | 50.0% |
| 1994 Q1 | 100 Thousand USD | 0.0% |
| 1993 FY | -500 Thousand USD | 37.5% |
| 1993 Q4 | 100 Thousand USD | 200.0% |
| 1993 Q3 | -100 Thousand USD | 50.0% |
| 1993 Q2 | -200 Thousand USD | 33.33% |
| 1993 Q1 | -300 Thousand USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 FY | -800 Thousand USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | -800 Thousand USD | -300.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | -200 Thousand USD | 60.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | -500 Thousand USD | 54.55% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 95.948% |
| Prenetics Global Limited | -62.72 Million USD | 84.98% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -508.592% |
| CareDx, Inc | -190.28 Million USD | 95.049% |
| Exact Sciences Corporation | -204.14 Million USD | 95.385% |
| Exagen Inc. | -23.68 Million USD | 60.23% |
| Inotiv, Inc. | -105.14 Million USD | 91.04% |
| Guardant Health, Inc. | -479.44 Million USD | 98.035% |
| Biodesix, Inc. | -52.14 Million USD | 81.933% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -258.343% |
| Precipio, Inc. | -5.85 Million USD | -60.96% |
| iSpecimen Inc. | -11.09 Million USD | 15.122% |
| Natera, Inc. | -434.8 Million USD | 97.833% |
| Aspira Women's Health Inc. | -16.69 Million USD | 43.553% |
| Standard BioTools Inc. | -74.65 Million USD | 87.381% |
| 23andMe Holding Co. | -666.7 Million USD | 98.587% |
| Castle Biosciences, Inc. | -57.46 Million USD | 83.606% |
| Personalis, Inc. | -108.29 Million USD | 91.301% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 89.353% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | 5.289% |
| OpGen, Inc. | -32.66 Million USD | 71.162% |
| T2 Biosystems, Inc. | -50.07 Million USD | 81.187% |
| Myriad Genetics, Inc. | -112 Million USD | 91.588% |
| ICON Public Limited Company | 612.33 Million USD | 101.539% |
| NeoGenomics, Inc. | -87.96 Million USD | 89.29% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -508.592% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 101.115% |
| RadNet, Inc. | 3.04 Million USD | 409.494% |
| MDxHealth SA | -43.1 Million USD | 78.142% |
| Psychemedics Corporation | -4.15 Million USD | -126.793% |
| Illumina, Inc. | -1.16 Billion USD | 99.189% |
| Check-Cap Ltd. | -17.56 Million USD | 46.374% |
| Twist Bioscience Corporation | -208.72 Million USD | 95.486% |
| DarioHealth Corp. | -59.42 Million USD | 84.147% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 94.386% |
| Sera Prognostics, Inc. | -36.24 Million USD | 74.005% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | 6.354% |
| OPKO Health, Inc. | -188.86 Million USD | 95.012% |
| Medpace Holdings, Inc. | 282.81 Million USD | 103.331% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | 7.244% |
| Prenetics Global Limited | -62.72 Million USD | 84.98% |
| Mainz Biomed B.V. | -26.29 Million USD | 64.173% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -18.697% |
| Trinity Biotech plc | -24.01 Million USD | 60.775% |
| Neuronetics, Inc. | -30.18 Million USD | 68.793% |
| Sotera Health Company | 51.37 Million USD | 118.337% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -18.697% |